gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Recrudescence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, D; Cannet, C; Hiestand, P; Rausch, M; Rudin, M | 1 |
| Baumann, DR; Cannet, C; Foster, CA; Hiestand, P; Rausch, M; Rudin, M | 1 |
2 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Recrudescence
| Article | Year |
|---|---|
MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE.
Topics: Acute Disease; Animals; Brain; Chronic Disease; Contrast Media; Dextrans; Encephalomyelitis, Autoimmune, Experimental; Ferrosoferric Oxide; Heterocyclic Compounds; Image Enhancement; Inflammation; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Monocytes; Multiple Sclerosis; Organometallic Compounds; Oxides; Peripheral Nervous System; Rats; Rats, Inbred Lew; Recurrence | 2003 |
Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Topics: Acute Disease; Animals; Blood-Brain Barrier; Brain; Contrast Media; Dextrans; Encephalomyelitis, Autoimmune, Experimental; Female; Ferrosoferric Oxide; Fingolimod Hydrochloride; Heterocyclic Compounds; Immunohistochemistry; Immunosuppressive Agents; Iron; Macrophages; Magnetic Resonance Imaging; Magnetite Nanoparticles; Organometallic Compounds; Oxides; Propylene Glycols; Rats; Rats, Inbred Lew; Receptors, G-Protein-Coupled; Receptors, Lysophospholipid; Recurrence; Sphingosine | 2004 |